Orosur Mining Inc Announces Consultant Exercises Options
Application has been made for the 83,333 Common Shares, which rank pari passu with the existing Common Shares in issue, to be admitted to trading on AIM ('Admission'). It is expected that Admission will become effective and dealings will occur at 8:00am UK time on or around April 25, 2025.
No current members of the board, or Company executives have exercised any options.
Following Admission and for the purposes of the Disclosure Guidance and Transparency Rules, the Company will have 312,523,237 Common Shares in issue. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.
Following Admission, the Company will have 4,961,668 options outstanding.
For further information, visit www.orosur.ca, follow on X @orosurm or please contact:
Orosur Mining Inc
Louis Castro, Chairman,
Brad George, CEO
[email protected]
Tel: +1 (778) 373-0100
SP Angel Corporate Finance LLP - Nomad & Joint Broker
Jeff Keating / Jen Clarke / Devik Mehta
Tel: +44 (0) 20 3470 0470
Turner Pope Investments (TPI) Ltd - Joint Broker
Andy Thacker/James Pope
Tel: +44 (0)20 3657 0050
Flagstaff Communications and Investor Communications
Tim Thompson
Mark Edwards
Fergus Mellon
[email protected]
Tel: +44 (0)207 129 1474
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Orosur Mining Inc.
Orosur Mining Inc. (TSXV:OMI)(AIM:OMI) is a minerals explorer and developer currently operating in Colombia, Argentina and Nigeria.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: Orosur Mining Inc
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
4 minutes ago
- Business Wire
Deadline Alert: Charter Communications, Inc. (CHTR) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP reminds investors of the upcoming October 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Charter Communications, Inc. ('Charter' or the 'Company') (NASDAQ: CHTR) common stock between , inclusive (the 'Class Period'). IF YOU SUFFERED A LOSS ON YOUR CHARTER INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS. What Happened? On July 25, 2025, Charter released its second quarter 2025 financial results, reporting that total internet customers had declined by 117,000, compared to about 100,000 in the second quarter of 2024, when adjusted to remove the prior year's impact of Affordable Connectivity Program ("ACP") related disconnected. The Company's total video customers also decreased by 80,000. On this news, Charter's stock price fell $70.25, or 18.5%, to close at $309.75 per share on July 25, 2025, thereby injuring investors. What Is the Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the impact of the ACP end was a material event the Company was unable to manage or promptly move beyond; (2) the ACP end was actually having a sustaining impact on Internet customer declines and revenue; (3) neither was the Company executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (4) the Internet customer declines and broader failure of Charter's execution strategy created much greater risks on business plans and earnings growth than reported; (5) accordingly, the Company had no reasonable basis to state the Company was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Charter common stock during the Class Period, you may move the Court no later than October 14, 2025 to request appointment as lead plaintiff in this putative class action lawsuit. Contact Us to Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Charles Linehan, Esq. Glancy Prongay & Murray LLP 1925 Century Park East, Suite 2100 Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150 Toll-Free: 888-773-9224 Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. If you inquire by email, please include your mailing address, telephone number and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
34 minutes ago
- Business Wire
Deadline Approaching: CTO Realty Growth, Inc. (CTO) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased CTO Realty Growth, Inc. ('CTO' or the 'Company') (NYSE: CTO) securities between February 18, 2021 and June 24, 2025, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CTO REALTY GROWTH, INC. (CTO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On June 25, 2025, Wolfpack Research published a report alleging, among other things, that CTO is 'engag[ing] in accounting shenanigans like using a sham loan to cover up a top tenant's failure.' Specifically, the report claims that the Company's management 'used a sham loan to hide the collapse of a top tenant from shareholders,' 'obfuscates its impotence by excluding recurring capex from [Adjusted Funds From Operation ('AFFO')],' and 'makes more money for themselves sabotaging the future of the company by overpaying for properties.' On this news, CTO's stock price fell $0.98, or 5.4%, to close at $17.10 per share on June 25, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) CTO's dividends were less sustainable than Defendants had led investors to believe; (2) the Company used deceptive and unsustainable practices to artificially inflate its AFFO and overstate the true profitability of its Ashford Lane property; (3) accordingly, CTO's business and/or financial prospects were overstated; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired CTO securities during the Class Period, you may move the Court no later than October 7, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
an hour ago
- Yahoo
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its 'GROW' strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwill of ~16%. Novonesis is well positioned to continue to drive strong performance in biosolutions. The company is present across multiple end-markets with strong capabilities to deliver value-adding solutions for tailored customer needs. Novonesis' distinct position is built on three capabilities: deep customer understanding, unparalleled innovation and an exceptional ability to scale and produce robust and affordable biosolutions. In a world with a growing population, increasing energy needs, evolving nutritional and health trends, as well as climate risks, the company sees a strong and increasing demand for biosolutions. Ester Baiget, President & CEO: 'We are clearly on track to deliver on our 2025 targets that were set when we announced the combination. The potential for biosolutions continues to be strong and Novonesis is uniquely positioned to achieve accelerated profitable growth towards 2030 and beyond. We focus on growing our core, where we continue to see strong demand, and we significantly invest in our distinct capabilities to further expand our market and innovation leadership. We believe the more we grow, the more long-term value and impact we create for shareholders, customers, people and the planet.' Novonesis' proven growth matrix is a well-balanced combination of end-market volume growth, pricing, upselling and adjacencies, as well as penetration. The company continues to explore areas with long-term growth opportunities targeting applications and markets with significant untapped potential. The new explorative areas in focus are Biopharma Processing Aids, Future Fuels and Chemicals, and Functional Food Proteins. 2030 targets* Organic sales growth CAGR of 6-9%. The organic sales growth is expected to be mainly driven by volume, including synergies, as well as an annual price contribution between 1-2%. Both the Food & Health and Planetary Health Biosolutions divisions are expected to grow within the Group range, and emerging markets are expected to grow stronger than developed markets. An adjusted EBITDA margin expected at around 39% by 2030, based on current currency exchange rates. The strategy period includes synergies, as well as significant investments in innovation, commercial and go-to-market capabilities to support growth on both the short- and long-term time horizons. The adjusted ROIC excl. goodwill is expected at around 16% by 2030, increasing from pro forma 8.3% in 2024. A reconfirmation of non-financial ambitions and targets, with investments to realize these targets. Modeling assumptions* Capex as a percentage of sales will be elevated at the beginning of the strategy period to cater for sustained high growth, also beyond the strategy period. A new ERP system and investments to support sustainability efforts are also included in the Capex. We invest globally to cater for increasing demand, creating flexibility on a global and regional basis. The Capex level will gradually decrease to high-single-digit as a percent of sales towards the end of the strategy period. A net debt/EBITDA ratio is targeted at around 1.5x in alignment with the capital allocation policy. A continued clear capital allocation model with an expected dividend payout ratio of 40-60% of adj. net profit. The 2030 strategy will be presented and commented on in combination with the extended H1 2025 conference call on August 21 at 09.00 CET. Slides will be shared ahead of the conference call. * 2025 as a baseline. All targets assume constant currencies, no impact from acquisitions or divestments, no major changes or disruptions to the current state of the global economy, including global trade conditions. Contact information Investor Relations Tobias Bjorklund, +45 3077 8682, tobb@ Anders Enevoldsen, +45 5350 1453, adev@ Katrine Spedtsberg Poulsen, kats@ Media Relations Jens Gamborg, +45 3077 7182, jgam@ Forward-looking statements This announcement includes forward-looking statements, including statements relating to the operating, financial and sustainability performance and results of the group and/or the industry in which it operates. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as "aim", "anticipate", "assess", "assume", "believe", "continue", "could", "estimate", "expect", "goal", "hope", "intend", "may", "objective", "plan", "position", "potential", "predict", "project", "risk", "seek", "should", "target", "will", "would", or any variations of such words or other words with similar meanings. Any such statements are subject to risks and uncertainties that could cause the group's actual results to differ materially from the results discussed in such forward-looking statements. Prospective information is based on management's then current expectations or forecasts. Such information is subject to the risk that such expectations or forecasts, or the assumptions underlying such expectations or forecasts, may change. Unless as required by applicable laws, the group assumes no obligation to update any such forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. Factors that could cause the group's actual results to differ materially from those expressed in its forward-looking statements include, but are not limited to: i) unexpected developments in the ability to develop and market new products; ii) fluctuations in the demand for the group's products, market-driven price decreases, industry consolidation, and launches of competing products or disruptive technologies in the group's core business areas; iii) changes in the ability to protect and enforce the company's intellectual property rights; iv) significant litigation or breaches of contract; v) the materialization of the company's growth platforms; vi) political conditions, such as acceptance of enzymes produced by genetically modified organisms; vii) global economic and capital market conditions, including, but not limited to, currency exchange rates (USD/DKK and EUR/DKK in particular, but not exclusively), interest rates, and inflation; viii) significant price decreases for input and other materials that compete with the group's solutions; and ix) changes in laws or interpretations thereof, including those related to reimbursement, intellectual property protection, marketing, and taxation (including tariffs and duties). New risk factors can arise, and it may not be possible for management to predict all such risk factors, nor to assess the impact of all such risk factors on the group's business or the extent to which any individual risk factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as predictions of actual future events or in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
